| Net loss |
| Depreciation and amortization |
5.9M |
| Stock-based compensation |
4.56M |
| Loss (gain) on disposal of equipment, software, and leasehold improvements |
| Equity in net loss of Rhapsody and other investments |
629K |
| Loss on sale of equity investments, net |
| Excess tax benefit from stock option exercises |
| Gain on deconsolidation of Rhapsody |
| Accrued loss (gain) on excess office facilities |
| Deferred income taxes, net |
-198K |
| Accrued restructuring and other charges |
| Other |
112K |
| Trade accounts receivable |
-1.74M |
| Prepaid expenses and other assets |
1.16M |
| Accounts payable |
450K |
| Accrued and other liabilities |
-872K |
| Net cash used in operating activities |
-22.29M |
| Purchases of equipment, software, and leasehold improvements |
-2.01M |
| Purchases of short-term investments |
-59.12M |
| Proceeds from sales and maturities of short-term investments |
68.47M |
| Decrease (increase) in restricted cash equivalents and investments, net |
190K |
| Payment in connection with the restructuring of Rhapsody |
| Payment of acquisition costs, net of cash acquired |
-150K |
| Repayment of temporary funding upon deconsolidation of Rhapsody |
| Net cash provided by (used in) investing activities |
13.49M |
| Net proceeds from sale of common stock under employee stock purchase plan and exercise of stock options |
| Excess tax benefit from stock option exercises |
| Net proceeds from sales of interest in Rhapsody |
| Net cash provided by financing activities |
-677K |
| Effect of exchange rate changes on cash and cash equivalents |
450K |
| Net increase (decrease) in cash and cash equivalents |
-9.03M |
| Cash and cash equivalents, beginning of period |
47.32M |
| Cash and cash equivalents, end of period |
38.28M |
| Cash received from income tax refunds |
531K |
| Cash paid for income taxes |
1.88M |
